Sleep Studies

We schedule sleep studies 7 nights a week and offer several locations for your convenience.


Contact Us Today


Latest Technology

Provent Sleep Apnea Therapy is a prescription-only therapy for the treatment of obstructive sleep apnea (OSA). 

Read More


Medical Accreditation

We are accredited by the American Academy of Sleep Medicine (AASM). Additionally, AASM accreditation is the gold standard by which other organizations and companies evaluate sleep programs.

Read More


News Feeds

AASM Research News

The latest news from the American Academy of Sleep Medicine
American Academy of Sleep Medicine
  1. Study finds increased risk of death in people with narcolepsy
    A study in the March issue of SLEEP is the first to identify increased mortality in narcolepsy. Results show that narcolepsy is associated with approximately 1.5-fold excess mortality relative to those without narcolepsy.
  2. Study of Gulf War vets finds link between sleep quality and brain volume
    A study in the March issue of SLEEP found an association between poor sleep quality and reduced gray matter volume in the brain’s frontal lobe among a sample of Gulf War veterans.
  3. Study links CPAP therapy with improved golf performance
    A new study in the Dec. 15 issue of the Journal of Clinical Sleep Medicine suggests that middle-aged men with obstructive sleep apnea (OSA) canimprove their golf score by using CPAP therapy. 
  4. Study examines reasons for CPAP adherence among teens
    Health education, peer support groups, and developmentally appropriate individualized support strategies may be important in promoting CPAP therapy adherence among adolescents with obstructive sleep apnea, according to a qualitative study published in the Dec. 15 issue of the Journal of Clinical Sleep Medicine.
  5. PCORI funding awarded to Sleep Apnea Patient-Centered Outcomes Network
    Earlier this week the Patient-Centered Outcomes Research Institute (PCORI) approved $93.5 million to support 29 clinical research data networks.
You are here: Home